Global Ciprofloxacin HCl Market size is expected to grow from USD 970.53 Million in 2023 to USD 1684.78 Million by 2032, at a CAGR of 6.32% during the forecast period (2024–2032).
Ciprofloxacin HCl, a member of the fluoroquinolone family of antibiotics, is a broad-spectrum medication. It is effective against both Gram-positive and Gram-negative bacteria, as well as a variety of other microorganisms. Numerous bacterial illnesses, including urinary tract infections (UTIs), skin and soft tissue infections, respiratory tract infections, and intra-abdominal infections, are treated with ciprofloxacin.